Fact of the day

Bedtime doses of elinzanetant, a nonhormonal drug for menopause hot flashes, did not cause residual next-day sleepiness in postmenopausal women; in a pooled analysis of two phase III trials it actually improved daytime sleepiness scores over 12 weeks.

Evidence

marketing claim

⚠What it shows: Reported by MedPage Today and not verified by us: we could not trace this story to a published paper, so treat it as news rather than evidence we have checked.